Real-time enrollment status for this crohn's disease clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:29 PM UTC
| NCT Number | NCT06937099 |
| Recruiting Status | Recruiting |
| Condition | Crohn's Disease |
| Phase | PHASE3 |
| Target Enrollment | 290 participants |
| Active Locations | 35 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | July 7, 2026 (1 week ago) |
As of July 19, 2026: Clinical trial NCT06937099 is currently recruiting participants. This phase3 study for crohn's disease is actively seeking new participants at 35 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06937099 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06937099 was last updated 1 week ago (July 7, 2026). HelloStudys verifies this status automatically.